BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy solutions company, announces that it has ranked No. 44 on the prestigious Philadelphia100 list of 100 fastest growing, privately held entrepreneurial companies in the Greater Philadelphia Region. Run by the Entrepreneurs’ Forum of Greater Philadelphia, the ranking was announced at an awards event, Oct. 13, 2022, and a printed list will be published in the Philadelphia Inquirer.
“The rigorous competition in the selection process makes the Philadelphia100 a coveted award and we are thrilled to have ranked on the list for a third year in a row,” says Dea Belazi, president and CEO, AscellaHealth. “Our remarkable growth can be credited to our single-source, end-to-end solutions that tighten the specialty pharmacy value chain. With a focus on optimizing access to expensive specialty and rare disease medications, improving clinical outcomes and always putting patients at the center of all our initiatives, it is extremely gratifying to earn this distinction.”
Started in 1988 by The Entrepreneurs’ Forum of Greater Philadelphia and the Wharton Small Business Development Center, the Philadelphia100 has recognized some of the region’s finest companies when they were just beginning to emerge: Mothers’ Work, Fiberlink, Urban Outfitters, Forman Mills, Kremer Laser Eye Center and Primavera Systems—to name a few.
Belazi adds, “The AscellaHealth team is honored to share the spotlight with such exceptional companies. We are proud to offer custom solutions that enhance the lives of specialty and rare disease patients in the Philadelphia region, throughout the country and globally.”
About AscellaHealth LLC
AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences manufacturers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Most recently, AscellaHealth has joined with its subsidiaries, Optime Care and Terebellum to form the AscellaHealth Family of Companies. Visit www.AscellaHealth.com.
